NVO - Novo Nordisk A/S logo

NVO

Novo Nordisk A/S

9.5/10top 1%Net income grew 100% of years20Y

Novo Nordisk A/S develops, manufactures, and distributes pharmaceutical products, focusing on diabetes, obesity, and rare diseases. Its offerings include insulin pens, hormone therapies, and treatment solutions for rare blood and endocrine disorders across multiple regions.

⚕️ Healthcare NYSE Listed 1982 kr DKK
$1,000 invested 30 years ago →$105,341today

Score Overview

1 Year
Score9.0
Net Growth19.06%
Net TrendGrew
Net Income Consistency—
Rev Growth6.06%
Rev TrendGrew
Revenue Consistency—
5 Years
Score9.4
Net Growth155.37%
Net TrendEvery year
Net Income Consistency—
Rev Growth132.81%
Rev TrendEvery year
Revenue Consistency—
10 Years
Score9.0
Net Growth221.57%
Net TrendEvery year
Net Income Consistency92%
Rev Growth193.25%
Rev Trend90%
Revenue Consistency94%
20 Years
Score9.5
Net Growth17x
Net TrendEvery year
Net Income Consistency96%
Rev Growth7x
Rev Trend95%
Revenue Consistency96%
30 Years
Score9.6
Net Growth66x
Net TrendEvery year
Net Income Consistency99%
Rev Growth20x
Rev Trend93%
Revenue Consistency99%
All Time
Score9.6
Net Growth199x
Net Trend95%
Net Income Consistency99%
Rev Growth77x
Rev Trend95%
Revenue Consistency99%

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-06-18
$ 43.19—
1 Year2025-06-18
$ 70.60-38.82%
5 Years2021-06-18
$ 36.9516.87%
10 Years2016-06-17
$ 20.38111.96%
20 Years2006-06-16
$ 1.9622x
30 Years1996-06-18
$ 0.41105x
All Time1982-01-04
$ 0.10416x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026kr 327.80Bkr 121.95Bkr 21.62B
2025kr 309.06Bkr 102.43Bkr 26.96B
2024kr 290.40Bkr 100.98Bkr 26.30B
2023kr 232.26Bkr 83.68Bkr 30.23B
2022kr 176.95Bkr 55.52Bkr 23.57B
2021kr 140.80Bkr 47.75Bkr 17.48B
2020kr 126.94Bkr 42.13Bkr 2.09B
2019kr 122.02Bkr 38.95Bkr 2.32B
2018kr 111.83Bkr 38.62Bkr 15.63B
2017kr 111.69Bkr 38.13Bkr 18.85B
2016kr 111.78Bkr 37.92Bkr 20.69B
2015kr 107.92Bkr 34.86Bkr 20.46B
2014kr 88.80Bkr 26.48Bkr 15.90B
2013kr 83.57Bkr 25.18Bkr 14.46B
2012kr 78.02Bkr 21.43Bkr 16.10B
2011kr 66.34Bkr 17.09Bkr 17.50B
2010kr 60.77Bkr 14.40Bkr 16.05B
2009kr 51.07Bkr 10.76Bkr 12.82B
2008kr 45.66Bkr 9.66Bkr 10.18B
2007kr 41.88Bkr 8.53Bkr 7.38B
2006kr 38.75Bkr 6.45Bkr 5.10B
2005kr 33.71Bkr 5.85Bkr 5.01B
2004kr 29.23Bkr 5.04Bkr 3.98B
2003kr 26.61Bkr 4.87Bkr 3.09B
2002kr 25.15Bkr 4.09Bkr 1.74B
2001kr 23.71Bkr 3.85Bkr 3.04B
2000kr 20.81Bkr 3.08Bkr 1.27B
1999kr 16.44Bkr 2.41Bkr 1.97B
1998kr 13.64Bkr 2.41Bkr 798M
1997kr 16.98Bkr 2.21Bkr 1.12B
1996kr 14.90Bkr 1.80Bkr 1.57B
1995kr 13.71Bkr 1.56Bkr 2.99B
1994kr 13.51Bkr 1.43Bkr 6.68B
1993kr 13.14Bkr 1.43Bkr 5.70B
1992kr 10.67Bkr 1.27Bkr 5.81B
1991kr 9.82Bkr 930Mkr 6.03B
1990kr 8.33Bkr 760Mkr 4.33B
1989kr 7.61Bkr 745Mkr 2.94B
1988kr 5.62Bkr 637Mkr 2.52B
1987kr 5.02Bkr 480Mkr 2.04B
1986kr 4.18Bkr 521Mkr 1.99B
1985kr 4.15Bkr 607Mkr 2.10B